Document Detail


A multiplexed cell assay in HepG2 cells for the identification of delta-5, delta-6, and delta-9 desaturase and elongase inhibitors.
MedLine Citation:
PMID:  20086206     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A multiplexed cell assay has been optimized to measure the activities of fatty acyl-CoA elongase, delta-5 desaturase (Delta5D), delta-6 desaturase (Delta6D), and delta-9 desaturase (Delta9D) together using (14)C-labeled tracers in HepG2 cells, which express the human stearoyl-CoA desaturase-1 isoform (SCD1) exclusively. The Delta5 and Delta9 desaturase activities are indexed by the efficient conversion of [1-(14)C]-eicosatrienoic acid (C20:3, cis-8,11,14) to (14)C-arachidonic acid (C20:4, cis-5,8,11,14) and the conversion of [1-(14)C]-stearic acid to (14)C-oleic acid (C18:1, cis-9), respectively. CP-74006 potently blocks the Delta5D activity with an IC(50) value of 20 nM and simplifies the metabolism of [1-(14)C]-alpha-linolenate (C18:3, cis-9,12,15) by accumulating (14)C-eicosatetraenoic acid (C20:4, cis-8,11,14,17) as the major (14)C-eicosatrienoic acid (C20:3, cis-11,14,17) and (14)C-docosatetraenoic acid (C22:4, cis-10,13,16,19) as the minor metabolites through Delta6 desaturation and elongation. This simplified metabolite spectrum enables the delineation of the Delta6D activity by comparing the combined Delta6D/elongase activity index of the (14)C-(C20:4/C18:3) ratio with the corresponding elongation index of the (14)C-(C20:3/C18:3) ratio following compound treatment. SC-26196 and sterculic acid specifically inhibit the Delta6D and Delta9D activities with an IC(50) value of 0.1 microM and 0.9 microM, respectively. This medium-throughput cell assay provides an efficient tool in the identification of specific desaturase and elongase inhibitors.
Authors:
Lei Zhang; Yeeman Ramtohul; Sebastien Gagné; Angela Styhler; Hao Wang; Jocelyne Guay; Zheng Huang
Related Documents :
4005276 - Transport of fatty acids across the membrane of human erythrocyte ghosts.
3919646 - The physiological role of oxygen-sensitive pyruvate dehydrogenase in mitochondrial fatt...
7705366 - Synthesis of phosphatidylcholine in the chloroplast envelope after import of lysophosph...
9293616 - On the effects of thia fatty acid analogues on hydrolases involved in the degradation o...
19216696 - The correlation between sonographic diagnosis and laparoscopic observations on fatty li...
3777356 - Fate of exogenous hyaluronic acid in the middle ear.
Publication Detail:
Type:  Journal Article     Date:  2010-01-19
Journal Detail:
Title:  Journal of biomolecular screening     Volume:  15     ISSN:  1552-454X     ISO Abbreviation:  J Biomol Screen     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-05     Completed Date:  2010-04-27     Revised Date:  2011-05-23    
Medline Journal Info:
Nlm Unique ID:  9612112     Medline TA:  J Biomol Screen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  169-76     Citation Subset:  IM    
Affiliation:
Merck Frosst Center for Therapeutic Research, Montreal, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetyltransferases / antagonists & inhibitors*,  chemistry,  metabolism
Acyl Coenzyme A / antagonists & inhibitors*,  chemistry,  metabolism
Biological Assay*
Carbon Radioisotopes / diagnostic use
Fatty Acid Desaturases / antagonists & inhibitors*,  chemistry,  metabolism
Hep G2 Cells
Humans
Inhibitory Concentration 50
Kinetics
Linoleoyl-CoA Desaturase / antagonists & inhibitors*,  chemistry,  metabolism
Models, Biological
Models, Chemical
Chemical
Reg. No./Substance:
0/Acyl Coenzyme A; 0/Carbon Radioisotopes; 362-66-3/stearoyl-coenzyme A; EC 1.14.19.-/Fatty Acid Desaturases; EC 1.14.19.3/Linoleoyl-CoA Desaturase; EC 1.14.99.-/delta-5 fatty acid desaturase; EC 2.3.1.-/Acetyltransferases; EC 2.3.1.-/fatty acid elongases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise-training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers...
Next Document:  Binding investigation of integrin alphavbeta3 with its inhibitors by SPR technology and molecular do...